News
Zacks Industry Outlook Highlights Vertiv, Roper and Jack Henry & Associates
For Immediate Release
Chicago, IL – June 5, 2026 – Today, Zacks Equity Research Vertiv VRT, Roper Technologies ROP and Jack Henry & Associates JKHY.
Industry: IT Services
Link: https://www.zacks.com
Zacks Industry Outlook Highlights Kla,Teradyne and Flex
PETS Q4 Earnings Call Focuses on Turnaround Foundation
PetMed Express, Inc. PETS used its fourth-quarter fiscal 2026 earnings call to emphasize stabilization rather than a clean recovery. Management said fiscal 2026 was a reset year marked by
Tilly's Q1 Earnings Call Highlights Turnaround Momentum
Tilly’s, Inc. TLYS used its first-quarter fiscal 2026 earnings call to press a simple message: the turnaround is no longer confined to isolated wins. Management said comparable sales growth, cleaner
Arcturus Therapeutics Highlights mRNA Pipeline, CF Data and Vaccine Expansion at Jefferies
Key Points
- Interested in Arcturus Therapeutics Holdings Inc.? Here are five stocks we like better.
- Arcturus Therapeutics is expanding beyond vaccines and is now emphasizing therapeutic mRNA
The Zacks Analyst Blog Highlights Berkshire, Eli Lilly, Walmart, Universal Health Realty Income and Utah
For Immediate Release
Chicago, IL – June 5, 2026 – Zacks.com announces the list of stocks and featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and
The Zacks Analyst Blog Highlights ORBX, MARS, JEDI, AIS and UFO
For Immediate Release
Chicago, IL – June 5, 2026 – Zacks.com announces the list of stocks and ETFs and featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest
The Zacks Analyst Blog Highlights UnitedHealth, Donaldson, Lowe's and ePlus
For Immediate Release
Chicago, IL – June 5, 2026 – Zacks.com announces the list of stocks and featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and
Bull of the Day: Marathon Petroleum (MPC)
Crude oil prices remain elevated, and despite a steady stream of headlines suggesting a diplomatic breakthrough between the United States and Iran, there is still little evidence that a lasting
Bear of the Day: DAQO New Energy (DQ)
The solar energy sector has quietly become one of the market's strongest performers this year, with many clean energy stocks staging impressive recoveries. Yet DAQO New Energy (DQ) continues to
The Zacks Analyst Blog Highlights Micron, Sandisk, Seagate, Dell and Comfort Systems
For Immediate Release
Chicago, IL – June 5, 2026 – Zacks.com announces the list of stocks and featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and
The Zacks Analyst Blog Highlights Micron, Advanced Micro Devices, Broadcom and NVIDIA
For Immediate Release
Chicago, IL – June 5, 2026 – Zacks.com announces the list of stocks and featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and
Five Below Q1 Earnings Call Shows Strategy Has More Runway
Five Below, Inc. FIVE used its first-quarter fiscal 2026 call to press a forward-looking case, not just celebrate a beat. Management argued the latest surge in traffic reflected deeper operating
Amgen Touts MariTide, AI Gains and 2026 Growth Plans at Jefferies Conference
Key Points
- Interested in Amgen Inc.? Here are five stocks we like better.
- Amgen highlighted strong first-quarter performance, with revenue up 6% year over year and non-GAAP EPS up 5%
Alvotech Nears Inflection Point With 5 U.S. Biosimilars Targeted by Year-End
Key Points
- Interested in Alvotech? Here are five stocks we like better.
- Alvotech says it is at an “inflection point,” with management expecting five U.S. biosimilars on the market by year-end
Altimmune Touts Pemvidutide Momentum Ahead of Phase 3 MASH Trial
Key Points
- Interested in Altimmune, Inc.? Here are five stocks we like better.
- Altimmune said it expects to begin enrolling patients in the second half of the year for its Phase 3 pemvidutide
Align Technology CFO: Global Growth, DSOs Offset North America Demand Pressure
Key Points
- Interested in Align Technology, Inc.? Here are five stocks we like better.
- Align Technology said international markets and North American DSOs are offsetting weakness in the U.S
Aldeyra Therapeutics Eyes FDA Feedback as Dry Eye Drug Faces Make-or-Break Moment
Key Points
- Interested in Aldeyra Therapeutics, Inc.? Here are five stocks we like better.
- Aldeyra Therapeutics is awaiting near-term FDA feedback on its dry eye drug reproxalap after a third
Akebia Therapeutics Sees Vafseo Uptake Rising as Access and Pipeline Milestones Near
Key Points
- Interested in Akebia Therapeutics, Inc.? Here are five stocks we like better.
- Vafseo uptake is improving, with Akebia saying the number of prescribing physicians rose 28% to about
Best Consumer Dividend Stocks to Buy Now: HAS, KVUE, MOV
Investors searching for reliable income in their portfolio may want to consider several consumer-focused companies that offer enticing dividend yields while also having promisng earnings outlooks
Rubrik Q1 Earnings Call Highlights
Key Points
- Interested in Rubrik, Inc.? Here are five stocks we like better.
- Rubrik delivered a record Q1, with subscription ARR rising 32% to $1.57 billion and total revenue up 39% to $387
Planet Labs PBC Q1 Earnings Call Highlights
Key Points
- Interested in Planet Labs PBC? Here are five stocks we like better.
- Planet Labs posted record Q1 revenue of $94 million, up about 42% year over year, and raised its full-year fiscal
Samsara Q1 Earnings Call Highlights
Key Points
- Interested in Samsara Inc.? Here are five stocks we like better.
- Samsara posted strong first-quarter results, with revenue up 31% to $479 million, annual recurring revenue nearing